Core Laboratories Inc. (CLB) stock
CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3010% above fair value
$9.11+0.10 (+1.11%)
Close on Nov 13, 2026Market cap $417.45MP/E 26.8Yield 0.44%
Core Laboratories cash
Cash and short-term investments held at the end of each period.
Core Laboratories's cash was $21.38M at Sep 30, 2026. For fiscal 2025 it was $22.70M, up 18.5% from the year before. The highest annual figure on record is $22.70M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.70M | +18.5% |
| FY2024 | Dec 31, 2024 | $19.16M | +26.7% |
| FY2023 | Dec 31, 2023 | $15.12M | -2.0% |
| FY2022 | Dec 31, 2022 | $15.43M | -12.9% |
| FY2021 | Dec 31, 2021 | $17.70M | +28.2% |
| FY2020 | Dec 31, 2020 | $13.81M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $21.38M | -16.6% |
| Q2 FY2026 | Jun 30, 2026 | $22.74M | -27.1% |
| Q1 FY2026 | Mar 31, 2026 | $22.82M | +3.2% |
| Q4 FY2025 | Dec 31, 2025 | $22.70M | +18.5% |
| Q3 FY2025 | Sep 30, 2025 | $25.63M | +19.3% |
| Q2 FY2025 | Jun 30, 2025 | $31.19M | +76.3% |
| Q1 FY2025 | Mar 31, 2025 | $22.11M | +48.2% |
| Q4 FY2024 | Dec 31, 2024 | $19.16M | +26.7% |
| Q3 FY2024 | Sep 30, 2024 | $21.47M | +29.2% |
| Q2 FY2024 | Jun 30, 2024 | $17.70M | -32.5% |
| Q1 FY2024 | Mar 31, 2024 | $14.91M | -8.4% |
| Q4 FY2023 | Dec 31, 2023 | $15.12M | -2.0% |
| Q3 FY2023 | Sep 30, 2023 | $16.62M | +21.0% |
| Q2 FY2023 | Jun 30, 2023 | $26.20M | +62.3% |
| Q1 FY2023 | Mar 31, 2023 | $16.29M | -8.0% |
| Q4 FY2022 | Dec 31, 2022 | $15.43M | +11.7% |
| Q3 FY2022 | Sep 30, 2022 | $13.73M | – |
| Q2 FY2022 | Jun 30, 2022 | $16.15M | – |
| Q4 FY2021 | Dec 31, 2021 | $17.70M | – |
| Q4 FY2020 | Dec 31, 2020 | $13.81M | – |
See a number that looks wrong?